Swedish Orphan Biovitrum

Swedish Orphan Biovitrum

Engages in the development, marketing, and distribution of orphan products and specialty pharmaceuticals.

HQ location
Solna kommun, Sweden
Website
Launch date
Market cap
$11.8b
Enterprise value
$13.4b
Share price
SEK288.20 SOBI.ST
Company register number
556038-9321
  • Edit
loading funding rounds…

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
SEK2021202220232024202520262027
Revenues0000000000000000000000000000
% growth2 %21 %18 %18 %8 %12 %11 %
EBITDA0000000000000000000000000000
% EBITDA margin37 %33 %33 %36 %37 %38 %39 %
Profit0000000000000000000000000000
% profit margin17 %14 %11 %15 %16 %19 %21 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue13 %13 %13 %14 %---

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Swedish Orphan Biovitrum

Edit
Light Chain Bioscience (Novimmune)
ACQUISITION by Swedish Orphan Biovitrum Jan 2020
Biovitrum
ACQUISITION by Swedish Orphan Biovitrum Nov 2009
Dova Pharmaceuticals
ACQUISITION by Swedish Orphan Biovitrum Sep 2019
CTI Biopharma (Formerly Cell Therapeutics)
ACQUISITION by Swedish Orphan Biovitrum May 2023